Facilities for Illness Management and Prevention researchers report nationwide estimates of 43.6 million COVID-19-associated diseases and 101,300 deaths within the US throughout October 2022 to September 2023, plus 33.0 million diseases and 100,800 deaths throughout October 2023 to September 2024. Individuals 65 years and older accounted for almost all of hospitalizations and deaths.
COVID-19 has continued to have an effect on the US well being care system by way of outpatient visits, hospitalizations, and deaths lengthy after the general public well being emergency declaration led to Might 2023. SARS-CoV-2 circulation has added strain throughout winter respiratory sickness seasons whereas different respiratory viruses proceed to flow into.
Present estimates feed choices on useful resource allocation and public well being coverage, however they can’t react to what they can’t see. Case reporting to the US Facilities for Illness Management and Prevention ended with the tip of the COVID-19 public well being emergency, eradicating a nationwide stream of case-based knowledge used earlier within the pandemic.
Mortality monitoring typically depends on demise certificates itemizing COVID-19 as an underlying or contributing explanation for demise. Relaxed reporting necessities, new variants, and diminished testing complicate estimates of illness burden. Even symptomatic folks typically don’t search care or testing, creating gaps in attributable sickness and demise.
Within the examine, “Estimated Burden of COVID-19 Sicknesses, Medical Visits, Hospitalizations, and Deaths within the US From October 2022 to September 2024,” revealed in JAMA Inner Medication, researchers utilized hierarchical Bayesian modeling and probabilistic mathematical multiplier fashions to estimate COVID-19-associated diseases, outpatient visits, hospitalizations, and deaths within the US from October 2022 to September 2024.
COVID-19 Hospitalization Surveillance Community (COVID-NET) knowledge got here from 89 counties and jurisdictional equivalents in 12 states, overlaying roughly 10% of the US inhabitants. Information included 94,363 contributors for October 2022 to September 2023 and 72,176 contributors for October 2023 to September 2024.
Focus of extreme outcomes
Throughout the 2022–2023 interval, there have been an estimated 43.6 million COVID-19-associated diseases, 10.0 million outpatient visits, 1.1 million hospitalizations, and 101,300 deaths.
Throughout the 2023–2024 interval, there have been an estimated 33.0 million COVID-19-associated diseases, 7.7 million outpatient visits, 879,100 hospitalizations, and 100,800 deaths.
Adults aged 65 years and older made up 17.7% of the overall US inhabitants throughout 2023–2024 and accounted for 47.9% of COVID-19-associated diseases. 65 and older accounted for 64.3% of COVID-19-associated outpatient visits, 67.6% of related hospitalizations, and 81.2% of deaths.
Prevention and therapy gaps
Vaccination and early antiviral therapy might forestall extreme COVID-19 penalties. Estimates in 2024 point out 18% of US adults aged 18 years and older and 30% of nursing house residents obtained a current COVID-19 vaccine. Outpatient antiviral therapy in 2024 reached fewer than one-half of adults aged 65 years and older.
Assumptions can start to form private decisions in addition to nationwide coverage when a surveillance community stops reporting and there’s a actual hazard that folks will assume the danger is gone. COVID-19 hasn’t gone away, and vaccines are nonetheless actively stopping extreme sickness and demise.
